BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38224274)

  • 1. Insight on the hepatitis B virus and host immune mechanisms in the context of occult hepatitis.
    El Said M; Alshanberi AM; Abouelmagd F; Shaikhomer M; Hassan FE
    Egypt J Immunol; 2024 Jan; 31(1):87-105. PubMed ID: 38224274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases.
    Franzè MS; Pollicino T; Raimondo G; Squadrito G
    Liver Int; 2022 May; 42(5):963-972. PubMed ID: 35246933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Occult HBV Infection Among Chronic Hepatitis C Patients in Upper Egypt.
    Thabit AG; Hassan MA; Agban MN; Makhlouf NA; Khalil NK; Hassan HM; El-Mokhtar MA
    Egypt J Immunol; 2017 Jan; 24(1):131-142. PubMed ID: 29120585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection.
    Cho J; Lee SS; Choi YS; Jeon Y; Chung JW; Baeg JY; Si WK; Jang ES; Kim JW; Jeong SH
    World J Gastroenterol; 2016 Nov; 22(42):9427-9436. PubMed ID: 27895431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult Hepatitis B virus (HBV) infection and challenges for hepatitis elimination: A literature review.
    de Almeida NAA; de Paula VS
    J Appl Microbiol; 2022 Mar; 132(3):1616-1635. PubMed ID: 34724308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult hepatitis B virus infection: detection and significance.
    Gerlich WH; Bremer C; Saniewski M; Schüttler CG; Wend UC; Willems WR; Glebe D
    Dig Dis; 2010; 28(1):116-25. PubMed ID: 20460899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on occult hepatitis B virus infection.
    Makvandi M
    World J Gastroenterol; 2016 Oct; 22(39):8720-8734. PubMed ID: 27818588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine profile during occult hepatitis B virus infection in chronic hepatitis C patients.
    Ribeiro CRA; de Almeida NAA; Martinelli KG; Pires MA; Mello CEB; Barros JJ; de Paula VS
    Virol J; 2021 Jan; 18(1):15. PubMed ID: 33435966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.
    Kitab B; Ezzikouri S; Alaoui R; Nadir S; Badre W; Trepo C; Chemin I; Benjelloun S
    Liver Int; 2014 Jul; 34(6):e144-50. PubMed ID: 24502524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Re-recognition of occult hepatitis B virus infection].
    Lu FM; Liao H; Liu YZ; Dou XG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 May; 53(5):445-449. PubMed ID: 31091598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of occult hepatitis B virus infection: an update for the clinician.
    Lledó JL; Fernández C; Gutiérrez ML; Ocaña S
    World J Gastroenterol; 2011 Mar; 17(12):1563-8. PubMed ID: 21472122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of occult hepatitis B virus infection in chronic hepatitis C.
    Coppola N; Onorato L; Pisaturo M; Macera M; Sagnelli C; Martini S; Sagnelli E
    World J Gastroenterol; 2015 Nov; 21(42):11931-40. PubMed ID: 26576082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of occult hepatitis B virus infection.
    Said ZN
    World J Gastroenterol; 2011 Apr; 17(15):1927-38. PubMed ID: 21528070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
    Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
    Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinical significance of occult hepatitis B virus infection among renal transplant recipients in Korea.
    Bae E; Park CH; Ki CS; Kim SJ; Huh W; Oh HY; Kang ES
    Scand J Infect Dis; 2012 Oct; 44(10):788-92. PubMed ID: 22681387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance.
    Mak LY; Wong DK; Pollicino T; Raimondo G; Hollinger FB; Yuen MF
    J Hepatol; 2020 Oct; 73(4):952-964. PubMed ID: 32504662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
    Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
    El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological and Molecular Diagnosis of Occult Hepatitis B Virus Infection in Hepatitis C Chronic Liver Diseases.
    Daef EA; Makhlouf NA; Ahmed EH; Mohamed AI; Abd El Aziz MH; El-Mokhtar MA
    Egypt J Immunol; 2017 Jan; 24(1):37-48. PubMed ID: 29120576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.